Spondyloarthritis & psoriatic arthritis
Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial
Authors' conclusion
in patients with psoriasis there was no evidence that early diagnosis of PsA by ES in primary care changes physical function at 24 months compared with SC.
Study context
- Population
- Patients with psoriasis in UK primary care, 135 general practitioner practices87 with PsA analysed (64 enhanced surveillance (ES), 23 standard care (SC))
- Participants
- 2,225 patients
- Comparison
- Enhanced surveillance for PsA vs standard care in primary care psoriasis patients
- ESn = 1,123
- SCn = 1,102reference
- Primary endpoint
- HAQ Disability Index (HAQ-DI) in participants diagnosed with PsA
- Follow-up
- 24 months post-registration
Methodological detailscluster, multicentre, prospective, parallel-group
- Cluster
- Multicentre
- Prospective
- Parallel-group
Primary result
As reported in the abstract
ES vs SCEstimate (95% CI)P value
HAQ-DI in participants diagnosed with PsA
aOR for HAQ-DI score of 0 0.64(0.17–2.38)
No evidence of a difference
aOR for higher (non-zero) HAQ-DI score 1.12(0.67–1.86)
P = 0.66Original publication
Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial. Rheumatology (Oxford). Published 22 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →